Yes, the immune system can target and destroy tumor cells through processes like immune surveillance. However, tumor cells often develop mechanisms to evade immune detection. They may downregulate major histocompatibility complex (MHC) molecules, secrete immunosuppressive factors, or recruit regulatory T cells to inhibit immune responses. Understanding these mechanisms has led to the development of immunotherapies, which aim to boost the immune system’s ability to fight cancer.
